Autolus Therapeutics plc. (AUTL) NASDAQ

$6.38 0.14 (2.24%)

Market Cap: $1.48B

As of 03/28/24 04:00 PM EDT. Market closed.

(AUTL)

Autolus Therapeutics plc. (AUTL)
NASDAQ

$6.38
0.14 (2.24%)

Market Cap: $1.48B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ... read more

autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. we are building a leading biotechnology company focussed on the development and commercialisation of engineered t-cell therapies for haematological and solid tumours. autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient’s own cells. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
Scale Space Building, White City, London, 58 Wood Lane, W12 7RZ.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Address
Scale Space Building, White City, London, 58 Wood Lane, W12 7RZ.
PRICE CHART FOR AUTOLUS THERAPEUTICS PLC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.24
Previous Close
$6.24
Days Range
$6.04 - $6.29
52 week range
$1.61 - $7.45
Volume
695,033
Avg. Volume (30 days)
1,190,888
Market Cap
$1.48B
Dividend Yield
-
P/E
-
Shares Outstanding
232,270,130
Open
$6.24
Previous Close
$6.24
Days Range
$6.04 - $6.29
52 week range
$1.61 - $7.45
Volume
695,033
Avg. Volume (30 days)
1,190,888
Market Cap
$1.48B
Dividend Yield
-
P/E
-
Shares Outstanding
232,270,130
FINANCIAL STATEMENTS FOR AUTOLUS THERAPEUTICS PLC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

FUNDS WITH A POSITION IN AUTOLUS THERAPEUTICS PLC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKSTONE INC.20,485,6110.59%No changeOther
TFG ASSET MANAGEMENT GP LTD8,000,00012.41%-33.33%Event Driven, Other
ADAGE CAPITAL PARTNERS GP, L.L.C.3,825,5320.05%NewOther
BLACKROCK INC.1,355,3390.00022%76.68%Other
UBS OCONNOR LLC538,7660.25%-8.05%Value
RENAISSANCE TECHNOLOGIES LLC159,6000.00159%-41.68%Other
D. E. SHAW & CO., INC.221,4890.00125%NewOther
ALPS ADVISORS INC128,1470.00248%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC86,2560.00006%No changeOther
CHANGE IN SHARES OUTSTANDING FOR AUTOLUS THERAPEUTICS PLC
STOCK BUYBACKS FOR AUTOLUS THERAPEUTICS PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.06%
1Q
12/31/2023
06/30/2023
0.14%
2Q
12/31/2023
03/31/2023
0.16%
3Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.06%
1Q
06/30/2023
0.14%
2Q
03/31/2023
0.16%
3Q
BUYBACK ANNOUNCEMENT(S) FOR AUTOLUS THERAPEUTICS PLC
LOADING...